← back to search

Alison Simmons

John Radcliffe Hospital · GB
Area of research
Immunology · Genetics
Research interest
Research interests include Inflammatory Bowel Disease, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and Cancer Immunotherapy and Biomarkers.
h-index
46
citations
15,574
works
173
NIH funding
primary concept
Medicine
email

Recent publications

Spatial fibroblast niches define Crohn's fistulae.
2026cited by 1position: contributordoi
Early-life Wnt4 expressing colon stromal cells orchestrate lifelong mucosal homeostasis via BMP-driven iNKT cell imprinting.
2026cited by 0position: contributordoi
Human Enteric Glia Diversity in Health and Disease: New Avenues for the Treatment of Hirschsprung Disease.
2025cited by 22position: contributordoi
Immune–epithelial–stromal networks define the cellular ecosystem of the small intestine in celiac disease
Nature Immunology 2025cited by 11position: middledoi
Immune-epithelial-stromal networks define the cellular ecosystem of the small intestine in celiac disease.
2025cited by 7position: contributordoi
Author Correction: Spatial fibroblast niches define Crohn's fistulae.
2025cited by 1position: contributordoi
Type I IFN-activated lung monocytes and macrophages as initiators and drivers of fibrosis at the alveolar barrier in IPF
2025cited by 0position: contributordoi
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
2024cited by 91position: contributordoi
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
2024cited by 76position: contributordoi
Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis.
2024cited by 21position: contributordoi
Goblet cell differentiation subgroups in colorectal cancer.
2024cited by 9position: contributordoi
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis.
2024cited by 8position: contributordoi
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
2024cited by 6position: contributordoi
A Roadmap for the Human Gut Cell Atlas
Nature Reviews Gastroenterology & Hepatology 2023cited by 48position: contributordoi
A Roadmap for the Human Gut Cell Atlas
Nature Reviews Gastroenterology & Hepatology 2023cited by 47position: middledoi
Intelectin-1 binds and alters the localization of the mucus barrier-modifying bacterium Akkermansia muciniphila.
2023cited by 33position: contributordoi
Pathogenesis of Fistulating Crohn's Disease: A Review.
2023cited by 26position: contributordoi
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis.
2023cited by 13position: contributordoi
A robust deep learning workflow to predict CD8 + T-cell epitopes.
2023cited by 12position: contributordoi
Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease.
2023cited by 10position: contributordoi
A systems approach evaluating the impact of SARS-CoV-2 variant of concern mutations on CD8+ T cell responses.
2023cited by 3position: contributordoi
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis
Cell 2022cited by 212position: middledoi
GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis
Cell 2022cited by 184position: contributordoi
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility.
2022cited by 154position: contributordoi
Intelectin-1 binds and alters the localization of the mucus barrier–modifying bacterium <i>Akkermansia muciniphila</i>
The Journal of Experimental Medicine 2022cited by 38position: middledoi
Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens.
2022cited by 28position: contributordoi
HLA-dependent variation in SARS-CoV-2 CD8 &lt;sup&gt;+&lt;/sup&gt; T cell cross-reactivity with human coronaviruses.
2022cited by 21position: contributordoi
Dual RNA sequencing reveals dendritic cell reprogramming in response to typhoidal Salmonella invasion.
2022cited by 16position: contributordoi
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool.
2022cited by 14position: contributordoi
Lymphatic endothelia stakeout cryptic stem cells.
2022cited by 2position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 18 papers (2019–2026) · 8 papers (2019–2026) · 7 papers (2020–2023)Chloe H Lee · John Radcliffe Hospital7 papers (2021–2026)Simon P L Travis · Medical Research Council5 papers (2020–2022)Lorena Preciado-Llanes · University of Oxford4 papers (2019–2022) · 4 papers (2019–2022)Miles Parkes · MRC Epidemiology Unit4 papers (2019–2024)Peter Irving · Imperial College London4 papers (2019–2024)Jan Bornschein · John Radcliffe Hospital4 papers (2021–2026)Eleanor Barnes · Oxford Health NHS Foundation Trust4 papers (2020–2022)Paul Klenerman · Centre for Global Health Research4 papers (2019–2025)Matthias Friedrich · Institute of Rheumatology4 papers (2021–2021)Melita A. Gordon · University of Liverpool4 papers (2019–2020)Simon J. Leedham · University of Oxford4 papers (2021–2021)John D Rioux · University Hospital of Zurich3 papers (2022–2023)Ling-Pei Ho · Imperial College London3 papers (2021–2026) · 3 papers (2019–2020)Paul R. Buckley · King's College London3 papers (2021–2022) · 3 papers (2021–2022)